

3 on a current fund
last 24 months
across filed funds
| Vehicle | Filed | Target | Sold to date | Investors |
|---|---|---|---|---|
| MGP Venture Fund III | October 2021 | $150M | $95M | 97 |
| MGC VENTURE PARTNERS QP 2018 | August 2018 | $125M | $26M | 41 |
| MGC VENTURE PARTNERS 2018 | June 2018 | $125M | $49M | 41 |
Amounts are Item 13 as filed: the target is the whole offering, and the amount sold is cumulative across amendments rather than a final close. The filing carries no per-investor amount, so a firm’s own cheque is not recoverable here.
6 partners are named across this firm’s filings, 3 of them on a fund it is deploying now.
| Partner | Activity | Categories | Board seats | Last 24mo |
|---|---|---|---|---|
| Robin Readnour | Selective | Biotech & pharma, Food & agriculture | 4 | 2 |
| - Mgc Vp 2018, SlpNot on the current fund | Quiet | None listed | 0 | 0 |
| Byron SmithNot on the current fund | Quiet | Digital health, Biotech & pharma, Climate & energy | 9 | 0 |
| Jason Ferguson | Quiet | None listed | 0 | 0 |
| Joseph Cook, Jr. | Quiet | Biotech & pharma, Medical devices, Climate & energy | 15 | 0 |
| Steven SingletonNot on the current fund | Quiet | None listed | 0 | 0 |
Activity is filed board seats in the last 24 months: 4+ Active, 2–3 Selective, 1 Slowing, none Quiet. A firm's tier totals its partners, so an active firm may be four partners with one seat each. It undercounts partners who invest without taking a board seat, and filings lag a closing by weeks, so Quiet means the paperwork is quiet, not the person.
Categories of MGP Ventures’s own portfolio companies, based on 22 with a verified or cited source.
Not a filing value: this is Lev’s own classification of each company, one company one vote regardless of how many of MGP Ventures’s partners are named on its board, shown only when we found a specific, checkable source. Companies with no source read as unclassified and are left out of the shares above.
| Firm | Shared boards | Companies |
|---|---|---|
| Canvas Ventures | 1 | airVet |
| Hatteras Venture Partners | 1 | ORIG3N |
| Healthquest Partners | 1 | CASTLE BIOSCIENCES |
| Rockmont Partners | 1 | MiNDERA |
| Sofinnova Venture Partners | 1 | CASTLE BIOSCIENCES |
| Tramway Venture Partners | 1 | Circular Genomics |
A shared board seat: a company where filings name a MGP Ventures partner and a partner at the other firm, both with a clean identity match. Not a claim either firm led or co-led the round, only that both are named on the same board.